Statistics

Total Visits

Views
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain20

File Visits

Downloads
763.pdf17

Select a period of time:

Number of views in the range

Views
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain17

Number of downloads in the range

Downloads
763.pdf17

Views

Views
October 20252
November 20251
December 20250
January 20261
February 20260
March 202613
April 20260
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • October 2025
    4
  • November 2025
    0
  • December 2025
    1
  • January 2026
    2
  • February 2026
    0
  • March 2026
    7
  • April 2026
    3
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Brazil2
Argentina1
Ecuador1
Finland1
Mexico1
Poland1
Portugal1
 

Top countries by downloads

Downloads
United States5
Ecuador1
Mexico1
 

Top cities views

Views
Katowice1
Nova Timboteua1
Tijuana1
Uberaba1
 

Top cities by downloads

Downloads